Replies to post #141219 on PharmaCyte Biotech Inc (PMCB)

[DragonBear]

They had trouble getting sufficient oxygen-wrong

Maybe ciab could solve that.

No it will not.

Again, Viacyte has already chosen a membrane technology from Gore for their PEC-Encap (VC-01) product. Which is already in Phase 1-2 testing, with a completion date of June 2021. There is no need to encapsulate, within a device that's already encapsulated. Neither does a biotech go through Phase 1-2 clinical trials, and then decides to start over. Throwing out 7 yrs of development work out the window.

PMCB has nothing of interest for Viacyte.

And again, and again, and again, science doesn't stand still. If Viacyte can get PEC-QT (VCTX210) to work in clinical trials, then VC-01 becomes a stop gap measure. With PMCB having nothing, remaining the farce that it is per the diabetes scam angle.